查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497773

生物晶片市场：按类型、製造技术、应用和最终用户划分 - 全球预测 2024-2030

Biochips Market by Type (Arrays, DNA Chips, Lab-On-A-Chip), Fabrication Technology (Microarrays, Microfluidics), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年生物晶片市场规模为202.9亿美元，预计2024年将达241亿美元，2030年将达到704亿美元，复合年增长率为19.44%。

生物晶片是放置在固体基板上的微观测试位点的集合，并透过同时执行多个测试来实现高通量和速度。生物晶片应用于多种领域，包括医学和药物研究、疾病诊断、药物发现、农业科学和环境保护。危及生命的疾病的日益流行和老年人口的增加正在推动生物晶片市场的成长。此外，由于生物技术领域的进步和生物晶片的采用增加，对个人化采用的需求不断增长。然而，生物晶片产品的高额初始投资正在阻碍市场成长。此外，新兴国家不利的报销情况和对该技术缺乏认识正在阻碍市场的全部潜力。此外，该领域的持续发展（例如奈米生物晶片）正在为该行业的风险投资公司和潜在先驱者创造充满希望的机会。探索微阵列技术的进步、透过消除杂讯来提高资料品质以及透过小型化增强生物晶片功能是其中的一些途径。

主要市场统计
基准年[2023] 202.9亿美元
预测年份 [2024] 241亿美元
预测年份 [2030] 704亿美元
复合年增长率（%） 19.44%

区域洞察

美国和加拿大占据美洲生物晶片市场的很大份额。随着医疗保健领域，特别是个人化医疗和基因研究的大量投资，生物晶片的应用范围显然正在扩大。特别是个人化医疗和基因研究的投资活跃，生物晶片的使用范围正在扩大。美洲是生物晶片製造中心，持有众多专利，展现了生物晶片技术的领先地位。在 EMEA（欧洲、中东和非洲）地区，欧盟国家凭藉其先进的医疗设施、不断提高的医疗保健意识和庞大的医疗保健预算，为生物晶片市场做出了巨大贡献。此外，欧盟也促进生物技术产业投资，支持生物晶片领域的研究与创新。这种支援包括为众多计划提供资金以及生物晶片技术的专利权。相较之下，中东和非洲虽然经济新兴，但尚未充分发挥生物晶片市场的潜力。然而，人们越来越认识到生物晶片在有效疾病诊断和个人化医疗方面的优势，预计该地区将出现成长。由于慢性病的增加和製药业的强劲成长，亚太地区对生物晶片的需求不断增加，特别是在中国、日本和印度。在医疗保健技术，特别是生物晶片方面有大量投资。

FPNV定位矩阵

FPNV定位矩阵对于评估供应商在生物晶片市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对生物晶片市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在生物晶片市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 危及生命的疾病发生率不断上升，老年人口不断增加
      • 癌症治疗中个人化医疗的需求不断增长
      • 就地检验的需求增加
    • 抑制因素
      • 与製造生物晶片产品相关的高成本
    • 机会
      • 基因组学和蛋白​​质组学领域的不断进步
      • 私营和公共部门增加对生物技术的投资
    • 任务
      • 与生物晶片製造和实施相关的严格规定
  • 市场区隔分析
    • 类型：用于照护现场的实验室晶片受到消费者的青睐，因为它提供快速、准确的结果。
    • 製造技术：微流体在病原体检测的照护现场诊断的广泛使用
    • 应用：生物晶片在药物发现、化合物辨识和标靶检验中的重要作用
    • 最终用户：生物晶片在生物技术和製药公司的新药发现和个人化医疗中越来越受欢迎。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章生物晶片市场：依类型

  • 大批
  • DNA晶片
  • 实验室晶片
  • 蛋白质晶片

第七章生物晶片市场製造技术

  • 微阵列
  • 微流体

第八章生物晶片市场：依应用分类

  • 临床诊断
  • 药物发现
  • 基因组学和蛋白​​质组学资讯来源

第九章生物晶片市场：依最终用户分类

  • 学术研究所
  • 生物技术和製药公司
  • 医院和诊断中心

第十章美洲生物晶片市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生物晶片市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲生物晶片市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Archer 的第一代生物晶片 gFET 设计透过与晶圆代工厂合作伙伴共同製造的检验
    • Optive 申请新型多重生物晶片专利
    • Nutcracker Therapeutics 在 C 系列资金筹措中筹集了 1.67 亿美元，以推进 mRNA 疗法和第一个基于生物晶片的製造平台的开发。
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-430D42AA0CE3

[182 Pages Report] The Biochips Market size was estimated at USD 20.29 billion in 2023 and expected to reach USD 24.10 billion in 2024, at a CAGR 19.44% to reach USD 70.40 billion by 2030.

A biochip is a collection of microscopic test sites arranged on a solid substrate that allows many tests to be performed simultaneously to achieve higher throughput and speed. Biochips are used in various fields, including medical and pharmaceutical research, disease diagnostics, drug discovery, agricultural science, and environmental protection. The growing prevalence of life-threatening disorders and the rise in the geriatric population are driving the growth of the biochips market. Moreover, advancements in the biotechnology sector along with the growing demand for personalized adoption owing to increased adoption of biochips. However, the high cost of biochip products, coupled with the requirement of high initial investment, hampers the market growth. Additionally, unfavorable reimbursement scenarios and a lack of awareness of this technology in developing countries inhibit the market's full potential. Furthermore, the continuous developments in the field, such as nano-biochips, are creating promising opportunities for venturing businesses and potential pioneers in the industry. Exploring advancements in microarray technology, improving data quality via noise removal, and enhancing biochip functional capabilities through miniaturization are a few such avenues.

KEY MARKET STATISTICS
Base Year [2023] USD 20.29 billion
Estimated Year [2024] USD 24.10 billion
Forecast Year [2030] USD 70.40 billion
CAGR (%) 19.44%

Regional Insights

The United States and Canada hold a significant share of the biochip market in the Americas; with heavy investments in the healthcare sector, especially in personalized medicine and genetic research, an increasing scope for biochip usage is evident. The Americas, being the hub of significant biochip manufacturers, holds numerous patents depicting its leadership in biochip technology. In the EMEA region, EU countries significantly contribute to the biochips market due to advanced medical facilities, heightened healthcare awareness, and substantial healthcare budgets. Additionally, the EU has stimulated investments in the Biotech industry, empowering research and innovation in the biochip field. This support includes funding for numerous projects and patent rights for biochip technology. In contrast, the Middle East and Africa, while rising on the economic front, are yet to fully embrace the potential of the biochip market. However, there is a growing awareness about the advantages of biochips in effective disease diagnosis and personalized medicine, indicating prospective growth in the region. The Asia Pacific region, particularly China, Japan, and India, has shown an increasing demand for biochips due to the rising chronic diseases prevalence and the robust growth of the pharmaceutical sector. Significant investment has been made in healthcare technologies, specifically in biochips.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Biochips Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing incidences of life-threatening disorder and rise in geriatric population
      • Growing demand of personalized medicine for the treatment of cancer
      • Increasing Demand for Point-of-care Testing
    • Market Restraints
      • High cost associated with the manufacturing of biochips products
    • Market Opportunities
      • Ongoing advancements in field of genomics and proteomics
      • Rising investments in the field of biotechnology from private & public sectors
    • Market Challenges
      • Stringent regulations associated with the manufacturing and implementation of biochips
  • Market Segmentation Analysis
    • Type: Consumer preference for lab-on-a-chip for point-of-care diagnostics as they provide quick and accurate results
    • Fabrication Technology: Extensive use of microfluidics for point-of-care diagnostics for pathogen detection
    • Application: Significant role of biochips in drug discovery utilized for compound identification and target validation
    • End-User: Growing preference for biochips by biotechnology & pharmaceutical companies for drug discovery and personalized medicine
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biochips Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biochips Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Archer's First-Generation Biochip gFET Design Validated by Joint Fabrication with a Foundry Partner

Archer Materials Limited, a semiconductor company that manufactures Biochip graphene field effect transistors, has successfully validated its first-generation gFET design through a Multi-Project Wafer obtained from an external German foundry partner. This collaboration marks the first joint fabrication between Archer and an external foundry partner, as the final fabrication processes were conducted in-house by the Company in Australia. The gFETs produced by the MPW have been proven to function as expected, including the demonstration of liquidgating, and are compatible with the Archer Biochip system platform. [Published On: 2023-11-09]

Opteev Files Patent for New Multiplex Biochip

Opteev Technologies has recently filed a patent for a groundbreaking multiplex biochip. This innovative polymer-based biochip has the capability to rapidly and accurately detect various respiratory pathogens like Flu, SARS-CoV-2, and RSV. With a remarkable accuracy rate of 99.49%, this biochip can detect complete viruses in samples such as nasal swabs or saliva within just one minute. The introduction of this technology is expected to bring numerous benefits to healthcare providers. [Published On: 2023-08-01]

Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform

Nutcracker Therapeutics, a biotech company, has successfully raised USD 167 million in Series C financing. This funding supports the expansion and advancement of Nutcracker's pipeline of mRNA medicines for cancer and the refinement of their RNA manufacturing platform and underlying technology. The company's unique approach combines RNA biochemistry, microfluidic engineering, semiconductor-such as biochips, and a proprietary nanoparticle delivery technology, resulting in an automated and isolated manufacturing pathway. [Published On: 2022-03-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biochips Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biochips Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACROBiosystems Inc., Agilent Technologies, Inc., Archer Materials Limited, Bio-Rad Laboratories, Inc., BioMerieux SA, Cellix Ltd. by Randox Laboratories Ltd., Diagnostic Biochips, Inc, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Horiba, Ltd., Illumina, Inc., Innovative Biochips, LLC, LI-COR, Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Micronit B.V., Nutcracker Therapeutics, Opteev, PerkinElmer Inc., Phalanx Biotech Group Inc. by WIN Semiconductors Corp., QIAGEN N.V., Sphere Fluidics Limited, Standard BioTools Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biochips Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Arrays
      • Cell Arrays
      • Tissue Arrays
    • DNA Chips
    • Lab-On-A-Chip
    • Protein Chips
  • Fabrication Technology
    • Microarrays
    • Microfluidics
  • Application
    • Clinical Diagnostics
    • Drug Discovery
    • Genomics & Proteomics Source
  • End-User
    • Academic & Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Diagnostics Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
      • 5.1.1.2. Growing demand of personalized medicine for the treatment of cancer
      • 5.1.1.3. Increasing Demand for Point-of-care Testing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the manufacturing of biochips products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in field of genomics and proteomics
      • 5.1.3.2. Rising investments in the field of biotechnology from private & public sectors
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with the manufacturing and implementation of biochips
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Consumer preference for lab-on-a-chip for point-of-care diagnostics as they provide quick and accurate results
    • 5.2.2. Fabrication Technology: Extensive use of microfluidics for point-of-care diagnostics for pathogen detection
    • 5.2.3. Application: Significant role of biochips in drug discovery utilized for compound identification and target validation
    • 5.2.4. End-User: Growing preference for biochips by biotechnology & pharmaceutical companies for drug discovery and personalized medicine
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biochips Market, by Type

  • 6.1. Introduction
  • 6.2. Arrays
  • 6.3. DNA Chips
  • 6.4. Lab-On-A-Chip
  • 6.5. Protein Chips

7. Biochips Market, by Fabrication Technology

  • 7.1. Introduction
  • 7.2. Microarrays
  • 7.3. Microfluidics

8. Biochips Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Diagnostics
  • 8.3. Drug Discovery
  • 8.4. Genomics & Proteomics Source

9. Biochips Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology & Pharmaceutical Companies
  • 9.4. Hospitals & Diagnostics Centers

10. Americas Biochips Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biochips Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biochips Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Archer's First-Generation Biochip gFET Design Validated by Joint Fabrication with a Foundry Partner
    • 13.3.2. Opteev Files Patent for New Multiplex Biochip
    • 13.3.3. Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOCHIPS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCHIPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOCHIPS MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOCHIPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOCHIPS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS & PROTEOMICS SOURCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS & PROTEOMICS SOURCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 353. POLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. POLAND BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 363. QATAR BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 364. QATAR BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 373. RUSSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 374. RUSSIA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 375. RUSSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 376. RUSSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 377. RUSSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 378. RUSSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 383. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 384. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 385. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 386. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 387. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 388. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 389. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 390. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 391. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 392. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 393. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 394. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 395. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2023 (USD MILLION)
  • TABLE 396. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2024-2030 (USD MILLION)
  • TABLE 397. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 398. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 399. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 400. SOUT